Global Respiratory Drug Market Size, Share, Trends and Forecast 2022-2030

Description

Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
Industry Insights

Due to the COVID-19 pandemic, the global Respiratory Drug market size is estimated to be worth US$ 43040 million in 2021 and is forecast to a readjusted size of US$ 64160 million by 2028 with a CAGR of 5.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Respiratory Drug market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Respiratory Drug landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.

Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.

North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.

Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.

This report focuses on Respiratory Drug volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Respiratory Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, India and China, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Respiratory Drug market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Inhalable & Nasal Spray

Oral

Others

Segment by Application

Hospital

Drugs Store

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GSK

AstraZeneca

Boehringer Ingelheim

Vertex

Roche

Novartis

Teva

Chiesi

Mylan

Sumitomo Dainippon

Merck

Beximco

TABLE OF CONTENT

1 Respiratory Drug Market Overview
1.1 Product Overview and Scope of Respiratory Drug

1.2 Respiratory Drug Segment by Type

1.2.1 Global Respiratory Drug Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Inhalable & Nasal Spray

1.2.3 Oral

1.2.4 Others

1.3 Respiratory Drug Segment by Application

1.3.1 Global Respiratory Drug Sales Comparison by Application: (2022-2028)

1.3.2 Hospital

1.3.3 Drugs Store

1.4 Global Respiratory Drug Market Size Estimates and Forecasts

1.4.1 Global Respiratory Drug Revenue 2017-2028

1.4.2 Global Respiratory Drug Sales 2017-2028

1.4.3 Respiratory Drug Market Size by Region: 2017 Versus 2021 Versus 2028

2 Respiratory Drug Market Competition by Manufacturers

2.1 Global Respiratory Drug Sales Market Share by Manufacturers (2017-2022)

2.2 Global Respiratory Drug Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Respiratory Drug Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Respiratory Drug Manufacturing Sites, Area Served, Product Type

2.5 Respiratory Drug Market Competitive Situation and Trends

2.5.1 Respiratory Drug Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Respiratory Drug Players Market Share by Revenue

2.5.3 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Respiratory Drug Retrospective Market Scenario by Region

3.1 Global Respiratory Drug Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Respiratory Drug Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Respiratory Drug Market Facts & Figures by Country

3.3.1 North America Respiratory Drug Sales by Country

3.3.2 North America Respiratory Drug Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Respiratory Drug Market Facts & Figures by Country

3.4.1 Europe Respiratory Drug Sales by Country

3.4.2 Europe Respiratory Drug Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Respiratory Drug Market Facts & Figures by Region

3.5.1 Asia Pacific Respiratory Drug Sales by Region

3.5.2 Asia Pacific Respiratory Drug Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Respiratory Drug Market Facts & Figures by Country

3.6.1 Latin America Respiratory Drug Sales by Country

3.6.2 Latin America Respiratory Drug Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Respiratory Drug Market Facts & Figures by Country

3.7.1 Middle East and Africa Respiratory Drug Sales by Country

3.7.2 Middle East and Africa Respiratory Drug Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Respiratory Drug Historic Market Analysis by Type

4.1 Global Respiratory Drug Sales Market Share by Type (2017-2022)

4.2 Global Respiratory Drug Revenue Market Share by Type (2017-2022)

4.3 Global Respiratory Drug Price by Type (2017-2022)

5 Global Respiratory Drug Historic Market Analysis by Application

5.1 Global Respiratory Drug Sales Market Share by Application (2017-2022)

5.2 Global Respiratory Drug Revenue Market Share by Application (2017-2022)

5.3 Global Respiratory Drug Price by Application (2017-2022)

6 Key Companies Profiled

6.1 GSK

6.1.1 GSK Corporation Information

6.1.2 GSK Description and Business Overview

6.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.1.4 GSK Respiratory Drug Product Portfolio

6.1.5 GSK Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Corporation Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.2.4 AstraZeneca Respiratory Drug Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Corporation Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Boehringer Ingelheim Respiratory Drug Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Vertex

6.4.1 Vertex Corporation Information

6.4.2 Vertex Description and Business Overview

6.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Vertex Respiratory Drug Product Portfolio

6.4.5 Vertex Recent Developments/Updates

6.5 Roche

6.5.1 Roche Corporation Information

6.5.2 Roche Description and Business Overview

6.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Roche Respiratory Drug Product Portfolio

6.5.5 Roche Recent Developments/Updates

6.6 Novartis

6.6.1 Novartis Corporation Information

6.6.2 Novartis Description and Business Overview

6.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Novartis Respiratory Drug Product Portfolio

6.6.5 Novartis Recent Developments/Updates

6.7 Teva

6.6.1 Teva Corporation Information

6.6.2 Teva Description and Business Overview

6.6.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Teva Respiratory Drug Product Portfolio

6.7.5 Teva Recent Developments/Updates

6.8 Chiesi

6.8.1 Chiesi Corporation Information

6.8.2 Chiesi Description and Business Overview

6.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Chiesi Respiratory Drug Product Portfolio

6.8.5 Chiesi Recent Developments/Updates

6.9 Mylan

6.9.1 Mylan Corporation Information

6.9.2 Mylan Description and Business Overview

6.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Mylan Respiratory Drug Product Portfolio

6.9.5 Mylan Recent Developments/Updates

6.10 Sumitomo Dainippon

6.10.1 Sumitomo Dainippon Corporation Information

6.10.2 Sumitomo Dainippon Description and Business Overview

6.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Sumitomo Dainippon Respiratory Drug Product Portfolio

6.10.5 Sumitomo Dainippon Recent Developments/Updates

6.11 Merck

6.11.1 Merck Corporation Information

6.11.2 Merck Respiratory Drug Description and Business Overview

6.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Merck Respiratory Drug Product Portfolio

6.11.5 Merck Recent Developments/Updates

6.12 Beximco

6.12.1 Beximco Corporation Information

6.12.2 Beximco Respiratory Drug Description and Business Overview

6.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Beximco Respiratory Drug Product Portfolio

6.12.5 Beximco Recent Developments/Updates

7 Respiratory Drug Manufacturing Cost Analysis

7.1 Respiratory Drug Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Respiratory Drug

7.4 Respiratory Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Respiratory Drug Distributors List

8.3 Respiratory Drug Customers

9 Respiratory Drug Market Dynamics

9.1 Respiratory Drug Industry Trends

9.2 Respiratory Drug Market Drivers

9.3 Respiratory Drug Market Challenges

9.4 Respiratory Drug Market Restraints

10 Global Market Forecast

10.1 Respiratory Drug Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Respiratory Drug by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Respiratory Drug by Type (2023-2028)

10.2 Respiratory Drug Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Respiratory Drug by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Respiratory Drug by Application (2023-2028)

10.3 Respiratory Drug Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Respiratory Drug by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Respiratory Drug by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample